Terms: = Gastric cancer AND ERCC4, XPF, 2072, ENSG00000175595, Q92889 AND Clinical Outcome
4 results:
1. Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer.
Chen ZH; Wang L; Luo LP
Genet Mol Res; 2014 Sep; 13(3):7484-91. PubMed ID: 25222248
[TBL] [Abstract] [Full Text] [Related]
2. Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer in a Chinese population.
Li J; Zuo X; Lv X; Kong F; Xu W; Yang S
Tumour Biol; 2014 Aug; 35(8):7569-74. PubMed ID: 24793015
[TBL] [Abstract] [Full Text] [Related]
3. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.
Fareed KR; Al-Attar A; Soomro IN; Kaye PV; Patel J; Lobo DN; Parsons SL; Madhusudan S
Br J Cancer; 2010 May; 102(11):1600-7. PubMed ID: 20461087
[TBL] [Abstract] [Full Text] [Related]
4. Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients.
Napieralski R; Ott K; Kremer M; Specht K; Vogelsang H; Becker K; Müller M; Lordick F; Fink U; Rüdiger Siewert J; Höfler H; Keller G
Clin Cancer Res; 2005 Apr; 11(8):3025-31. PubMed ID: 15837757
[TBL] [Abstract] [Full Text] [Related]
